3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
173
Lymphoma, Non-Hodgkin
155
Leukemia, Lymphocytic, Chronic, B-Cell
154
Lymphoma, Large B-Cell, Diffuse
134
Lymphoma, Follicular
131
Lymphoma, Mantle-Cell
94
Leukemia
68
Lymphoma, B-Cell, Marginal Zone
67
Waldenstrom Macroglobulinemia
49
Burkitt Lymphoma
43
Lymphoma, B-Cell
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Hodgkin Disease
36
Recurrence
24
Lymphoma, Large-Cell, Immunoblastic
24
Neoplasms
15
Myelodysplastic Syndromes
15
Lymphoma, Large-Cell, Anaplastic
15
Multiple Myeloma
13
Leukemia, Myeloid, Acute
12
Lymphoma, T-Cell, Cutaneous
9
Lymphoma, Extranodal NK-T-Cell
9
Leukemia, Hairy Cell
9
Intraocular Lymphoma
9
Hematologic Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Immunoblastic Lymphadenopathy
8
Sezary Syndrome
7
Mycosis Fungoides
7
Lymphoma, T-Cell
7
Interventions
tafasitamab
1
fludarabine
1
acalabrutinib
1
Valganciclovir
1
N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide
1
Lenalidomide
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pyloric Stenosis, Hypertrophic
×
Rituximab
×
Clear all
No trials found.